Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Canada: The Journal of Psychiatric Research recently reported that childhood cat ownership, particularly with rodent-hunting cats,.
Read Full NewsA yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.
A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.
The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.
1.
Dasatinib Fails to Improve Outcomes in CBF-AML
2.
Outcomes in Resected Melanoma Influenced by Timing of Recurrence
3.
The Boom in ADHD Coaching Has Few Rules
4.
FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC
5.
After two years, a significant left nasal obstruction was finally diagnosed.
1.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
2.
Tumor-Specific Fluorescent Peptide Navigation in Surgical Oncology
3.
Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis
4.
Understanding Epidural Hematoma: Symptoms, Causes and Treatment
5.
Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Navigating the Complexities of Ph Negative ALL - Part VII
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge